Infection prevention and control guidance for Middle East respiratory syndrome coronavirus (MERS-CoV) in acute care settings . : HP40-178/2017E-PDF
"The Public Health Agency of Canada (the Agency) has developed this document to provide infection prevention and control guidance to healthcare organizations and healthcare workers (HCWs) for: management of patients presenting to acute care settings in Canada, who have travelled to an affected area and/or been in contact with someone who has travelled to an affected area, within 14 days before onset of illness; management of HCWs and inpatients who have been exposed to a symptomatic confirmed case of MERS-CoV infection; and management of asymptomatic HCWs and inpatients who are RT-PCR positive for MERS-CoV"--P. 1.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.834047&sl=1
| Ministère/Organisme | Public Health Agency of Canada. |
|---|---|
| Titre | Infection prevention and control guidance for Middle East respiratory syndrome coronavirus (MERS-CoV) in acute care settings . |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Lignes directrices sur la prévention et le contrôle du coronavirus du syndrome respiratoire du Moyen-Orient (CoV-SRMO) dans les établissements de soins actifs. Cover title. "Publication date: March 2016." Includes bibliographical references. |
| Information sur la publication | Ottawa : Public Health Agency of Canada, 2016, c2017. |
| Description | ii, 21 p. |
| ISBN | 978-0-660-08028-4 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 160386 |
| Descripteurs | Respiratory diseases Preventive medicine Safety measures |